← Back to directory

Andrzej Januszewicz

Researcher Next ID · RN-041342

Researcher · Medicine

Hypertension Institute

Nashville, Poland

Accepting doctoral researchersFunding unknown
Works count
634
Citation count
20,645
H-index
60
i10-index
189

Research interests

Medicine
Hormonal Regulation and Hypertension
Adrenal and Paraganglionic Tumors
Blood Pressure and Hypertension Studies
Renal and Vascular Pathologies
Pituitary Gland Disorders and Treatments

Publications

  • 2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension

    European Journal of Internal Medicine · 2024 · https://doi.org/10.1016/j.ejim.2024.05.033

  • 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension

    Journal of Hypertension · 2023 · 10.1097/hjh.0000000000003480

  • Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

    The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(22)02034-7

  • Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac So

    Archives of Medical Science · 2022 · https://doi.org/10.5114/aoms/152921

  • International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers

    Nature Reviews Endocrinology · 2021 · https://doi.org/10.1038/s41574-021-00492-3

  • Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19

    Cardiovascular Research · 2020 · https://doi.org/10.1093/cvr/cvaa097

  • Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated O-Methylated Catecholamine Metabolites

    Clinical Chemistry · 2018 · https://doi.org/10.1373/clinchem.2018.291369

  • Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort

    The Lancet Diabetes & Endocrinology · 2017 · https://doi.org/10.1016/s2213-8587(17)30135-3

  • Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas

    The Journal of Clinical Endocrinology & Metabolism · 2017 · https://doi.org/10.1210/jc.2016-3829

  • Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention

    JAMA Oncology · 2017 · https://doi.org/10.1001/jamaoncol.2017.0223

  • Activation of Human T Cells in Hypertension

    Hypertension · 2016 · https://doi.org/10.1161/hypertensionaha.116.07237

  • Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial

    The Lancet Diabetes & Endocrinology · 2016 · https://doi.org/10.1016/s2213-8587(16)30100-0

  • Cardiovascular manifestations of phaeochromocytoma

    Journal of Hypertension · 2011 · https://doi.org/10.1097/hjh.0b013e32834a4ce9

  • Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

    New England Journal of Medicine · 2011 · 10.1056/nejmoa1007994

  • Effects of Renal Sympathetic Denervation on Blood Pressure, Sleep Apnea Course, and Glycemic Control in Patients With Resistant Hypertension and Sleep Apnea

    Hypertension · 2011 · https://doi.org/10.1161/hypertensionaha.111.173799

  • Clinical Predictors and Algorithm for the Genetic Diagnosis of Pheochromocytoma Patients

    Clinical Cancer Research · 2009 · https://doi.org/10.1158/1078-0432.ccr-09-1237

Current projects

    No projects listed.